SCHEMBL30898144

SCHEMBL30898144

COC(=C=O)/C=C/CN1CC2(CCN(C(=O)OC(C)(C)C)C2)C1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 1/20 0.38
▸ CYP11B2 P19099 1/20 0.37
▸ SCD5 Q86SK9 1/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ ACACB O00763 5/20 0.35
▸ GPR183 P32249 1/20 0.35
▸ HDAC1 Q13547 1/20 0.34
▸ CYP2D6 P10635 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.32
▸ NAMPT P43490 2/20 0.32
▸ SPR P35270 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30898045 0.96 SCD5 (0.36) RORCCYP11B2SCD5HDAC2ACACB
SCHEMBL30898023 0.94 RORC (0.38) RORCCYP11B2SCD5HDAC2ACACB
SCHEMBL30898235 0.94 SCD5 (0.38) RORCCYP11B2SCD5HDAC2ACACB
SCHEMBL30898090 0.93 CYP11B2 (0.39) RORCCYP11B2SCD5HDAC2ACACB
SCHEMBL30898219 0.92 CYP2D6 (0.38) RORCCYP11B2SCD5HDAC2ACACB
SCHEMBL30898071 0.92 RORC (0.34) RORCCYP11B2SCD5HDAC2GPR183
SCHEMBL30898215 0.91 GPR183 (0.37) RORCCYP11B2SCD5HDAC2ACACB
SCHEMBL30898156 0.90 CYP2D6 (0.41) CYP11B2CYP2D6ALDH1A1CYP1A2CYP2C9
SCHEMBL30898043 0.85 GPR183 (0.32) RORCHDAC2GPR183
SCHEMBL30898060 0.81 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024083086-A1 BICYCLIC DERIVATIVE INTEGRIN INHIBITOR 上海如凌生物医药有限公司 2024-04-25 — — WO disclosed
CN-117903171-A Integrin inhibitors of a class of bicyclic derivatives 上海如凌生物医药有限公司 2024-04-19 — — CN disclosed
Send feedback